Kang-Hao Liang

Years Active: 2021-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Monika Kumari, Kang-Hao Liang, Shih-Chieh Su, Hsiu-Ting Lin, Yu-Feng Lu, Ming-Jane Wu, Wan-Yu Chen, Han-Chung Wu
Multivalent mRNA Vaccine Elicits Broad Protection against SARS-CoV-2 Variants of Concern. Vaccines 12 (7) (2024)
Monika Kumari, Kang-Hao Liang, Shih-Chieh Su, Hsiu-Ting Lin, Yu-Feng Lu, Ming-Jane Wu, Wan-Yu Chen, Han-Chung Wu
Multivalent mRNA Vaccine Elicits Broad Protection against SARS-CoV-2 Variants of Concern. Vaccines 12 (7) (2024)
Monika Kumari, Kang-Hao Liang, Shih-Chieh Su, Hsiu-Ting Lin, Yu-Feng Lu, Ming-Jane Wu, Wan-Yu Chen, Han-Chung Wu
Multivalent mRNA Vaccine Elicits Broad Protection against SARS-CoV-2 Variants of Concern. Vaccines 12 (7) (2024)
Hsin-Jung Li, Feng-Yi Ke, Chia-Ching Lin, Mei-Yi Lu, Yi-Huei Kuo, Yi-Ping Wang, Kang-Hao Liang, Shin-Chang Lin, Ya-Hsuan Chang, Hsuan-Yu Chen, Pan-Chyr Yang, Han-Chung Wu
ENO1 Promotes Lung Cancer Metastasis via HGFR and WNT Signaling-Driven Epithelial-to-Mesenchymal Transition. Cancer research 81 (15) (2021)

Kang-Hao Liang.css-eqlu8i{font-size:small;padding-left:4px;}